Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders

Psychoneuroendocrinology

Volumn 20, Issue 8, 1995, Pages 789-819

  De Souza, Errol B ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Alzheimer's disease; Corticotropin releasing factor; Depression; Pituitary; Rheumatoid arthritis; Spleen; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

BIOCHEMISTRY; CENTRAL NERVOUS SYSTEM; HUMAN; IMMUNITY; PHARMACOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; ANIMALS; AROUSAL; AUTOIMMUNE DISEASES; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM DISEASES; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; HUMANS; INFLAMMATION; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029593616     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4530(95)00011-9     Document Type: Article

References (144)

1. Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells
2. Corticotropin releasing factor receptors: characterization and actions in the anterior pituitary gland
3. Corticotropin-releasing factor receptors distribution in brain pituitary and peripheral tissues
4. Effects of chronic stress on anterior pituitary and brain corticotropin-releasing factor receptors
5. Pharmacology of mesocortical dopamine neurons
6. The contribution of the nervous system to inflammation and inflammatory disease
7. Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system
8. Functional corticotropin-releasing factor receptors in neonatal spinal cord
9. Antipyretic effect of centrally administered CRF
10. Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3′,5′-monophosphate in cultured anterior pituitary cells
11. Corticotropin-releasing factorlike immunoreactivity in senile dementia of the Alzheimer type
12. A molecular basis for bidirectional communication between the immune and neuroendocrine systems
13. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
14. Regulation of the autonomic nervous system by corticotropin-releasing factor
15. Corticotropin-releasing factor effects on the sympathetic nervous system and oxygen consumption
16. Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism
17. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting a global defect in CRH secretion
18. Alternations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock
19. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain
20. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress
21. CRF receptor mediated stimulation of adenylate cyclase activity in rat brain
22. Expression cloning of a human corticotropinreleasing factor receptor
23. Cytochemical studies of corticotropin-releasing factor (CRF) receptors in anterior lobe corticotropes: binding, glucocorticoid regulation and endocytosis of [biotinyl-serl] CRF
24. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis
25. Corticoliberin, somatocrinin and amine contents in normal and parkinsonian human hypothalamus
26. Alzheimer's disease: a disorder of cortical cholinergic innervation
27. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumathoid arthritis and osteoarthritis
28. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis
29. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study
30. Corticotropin-releasing factor in cerebellar afferent systems: a combined immunohistochemistry and retrograde transport study
31. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution
32. CRH defects in Alzheimer's and other neurologic diseases
33. Role of corticotropin-releasing factor in neuropsychiatric disorders and neurodegenerative diseases
34. Corticotropin-releasing hormone receptors
35. Increased corticotropin-releasing factor receptors in rat cerebral cortex following chronic atropine treatment
36. Corticotropin-releasing factor: physiology., pharmacology and role in central nervous system and immune disorders
37. Corticotropin-releasing factor receptors in the pituitary gland and central nervous system: methods and overview
38. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study
39. Differential regulation of corticotropin-releasing factor receptors in anterior and intermediate lobes of pituitary and in brain following adrenalectomy in rats
40. Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification
41. Corticotropin-releasing factor receptors in rat pituitary gland: autoradiographic localization
42. Corticotropinreleasing factor receptors in human pituitary gland: autoradiographic localization
43. Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease
44. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease
45. Abnormalities in corticotropinreleasing hormone (CRH) in Alzheimer's disease and other human disorders
46. Corticotropin releasing factor receptors in human small cell lung carcinoma cells: radioligand binding., second messenger and northern blot analysis data
47. Different regulation of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzheimer's type
48. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety of stress responses?
49. Iontophoretic mapping of corticotropin-releasing factor (CRF) sensitive neurons in the rat forebrain
50. Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats
51. Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action
52. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease
53. The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary evidence from chemical cross-linking studies
54. Corticotropin-releasing factor receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization
55. Heterogeneity between brain and pituitary corticotropinreleasing factor receptors is due to differential glycosylation
56. Characterization of stable expression of cloned corticotropin releasing factor receptors
57. Normal pattern of labeling of cerebral cortical corticotropin-releasing factor (CRF) receptors in Alzheimer's disease: evidence from chemical cross-linking studies
58. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex
59. Novel processing for proopiomelanocortin in lymphocytes endotoxin induction of a new prohormone-cleaving enzyme
60. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress
61. Age-related alterations of hypothalamic-pituitaryadrenal axis function in male Fischer 344 rats
62. Age-related decreases in corticotropin-releasing factor (CRF) receptors in rat brain and anterior pituitary gland
63. ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression
64. Reduced ability of old male rats to release ACTH and corticosterone in response to CRF administration
65. Brain corticotropin-releasing factor and development
66. The ontogeny of brain receptors for corticotropin-releasing factor and the development of their functional association with adenylate cyclase
67. Evidence for basal and stress-induced release of corticotropin releasing factor in the push-pull cannulated median eminence of conscious free-moving rats
68. Behavioral and endocrine studies of corticotropin-releasing hormone in primates
69. Neurochemical and behavioral effects of corticotropinreleasing factor in the ventral tegmental area of the rat
70. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo
71. The role of IL-1 in the corticotropin-releasing factor and arginine vasopressin-induced secretion of immunoreactive β-endorphin by human peripheral blood mononuclear cells
72. Behavioral effects of corticotropin-releasing factor
73. Effects of aflupenthixol and naloxone on CRF-induced locomotor activation
74. Increased turnover of norepinephrine in red cerebral cortex during stress: role of the locus coeruleus
75. Endocrine responses to growth hormone releasing hormone and corticotropin releasing hormone in early-onset Alzheimer's disease
76. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis
77. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain
78. Stimulation of rat Blymphocyte proliferation by corticotropin-releasing factor
79. Cerebral spinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in Alzheimer's disease
80. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat spinal cord
81. CRF stimulates alpha-MSH secretion and cyclic AMP accumulation in rat pars intermedia cells
82. Distribution of corticotropinreleasing factor receptors in primate brain
83. Adrenocorticotropin production by the intermediate lobe of the rat pituitary
84. Corticotropin-releasing factor and ingestive behaviors
85. Spinal fluid CRF reduction in Alzheimer's disease
86. Classification of anterior pituitary cell types with immunoenzyme histochemistry
87. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy: corticotropin-releasing factor, β-endorphin and somatostatin
88. Reduced corticotropin-releasing factor receptor binding sites in the frontal cortex of suicide victims
89. Elevated concentration of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
90. Identification and characterization of a pituitary corticotropin-releasing factor binding protein by chemical cross-linking
91. The distribution of corticotropinreleasing factor-like immunoreactive neurons in rat brain
92. Intrahypothalamic action of corticotropin-releasing factor (CRF) to inhibit growth hormone and LH release in the rat
93. Physiology and pharmacology of corticotropin-releasing factor
94. Corticotropin-releasing factor in the olivocerebellar tract of rats: demonstration by light and electron microscopic immunohistochemistry and in situ hybridization histochemistry
95. Corticotropin-releasing factor inhibits gastric emptying in dogs: studies on its mechanism of action
96. Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanine nucleotides
97. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor
98. Central modulation of immunoreactive arginine vasopressin and oxytocin secretion into the hypophysial-portal circulation by corticotropin-releasing factor
99. Hemorrhage-induced secretion of corticotropin-releasing factor-like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids
100. CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites
101. Corticotropinreleasing factor as a transmitter in the human olivocerebellar pathway
102. Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease
103. Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat
104. Effect of long term administration of CRF on the pituitary-adrenal and pituitary-gonadal axis in the male rat
105. Identification of a corticotropin-releasing factor-binding protein in the plasma membrane of AtT-20 mouse pituitary tumor cells and its regulation by dexamethasone
106. CSF corticotropin-releasing hormone in depressed patients and normal control subjects
107. The corticotropinreleasing hormone stimulation test in patients with panic disorder
108. The adrenocortical stress-response in the aged male rat: impairment of recovery from stress
109. The neuroendocrinology stress and aging: the glucocorticoid cascade hypothesis
110. Organization of CRF immunoreactive cells and fibers in the rat brain: immunohistochemical studies
111. Age-related changes in hypothalamo-pituitaryadrenocortical axis activity in the rat
112. Mapping of CRF-immunoreactive nerve fibers in the medulla oblongata and spinal cord of the rat
113. Alteration in local cerebral glucose utilization following central administration of corticotropin-releasing factor in rats
114. Electrophysiology of corticotropin-releasing factor in nervous tissue
115. Electrophysiological actions of corticotropinreleasing factor in the central nervous system
116. Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression
117. 125I]corticotropin-releasing factor to blood immunocytes and its reduction in Alzheimer's disease
118. Enhancing effect of corticotropin-releasing factor neurohormone on production of interleukin-1 and interleukin-2
119. Inhibitory influence of corticotropin-releasing factor on components of sexual behavior in the male rat
120. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat
121. Capsaicin depletes corticotropin-releasing factor-like immunoreactive neurons in the rat spinal cord and medulla oblongata
122. Corticotropin-releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins
123. Corticotropin-releasing factor-like immunoreactivity and mRNA in human leukocytes
124. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats
125. Organization of ovine corticotropinreleasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study
126. Inhibition of gastric acid secretion in rats by intracerebral injection of corticotropin-releasing factor
127. CRF: central nervous system action to influence gastrointestinal function and role in the gastrointestinal response to stress
128. Selective activation of the mesocortical DA system by stress
129. Chemical and biological characterization of corticotropin-releasing factor
130. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin
131. Effects of CRF on spontaneous and sensory-evoked activity of locus coeruleus neurons
132. Corticotropin-releasing factor activates noradrenergic neurons of the locus ceruleus
133. Primary structure and functional expression of mouse pituitary and human brain corticotropin releasing factor receptor
134. Functional corticotropin-releasing factor (CRF) receptors in mouse spleen: evidence from adenylate cyclase studies
135. Corticotropin-releasing factor receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides
136. Corticotropin-releasing factor receptors in the brain-pituitary-immune axis
137. Corticotropin-releasing factor (CRF) receptors in mouse spleen: identification of receptor bearing cells as resident macrophages
138. Interactions between the neuroendocrine and immune systems common hormones and receptors
139. Reduction in corticotropin-releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy
140. Properties and regulation of high-affinity pituitary receptors for corticotropin-releasing factor
141. Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses
142. Brain and pituitary receptors for corticotropin-releasing factor: localization and differential regulation after adrenalectomy
143. Corticotropin-releasing factor mRNA is expressed in the inferior olives of rodents and primates